CorVel (NASDAQ:CRVL – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a report released on Friday.
CorVel Stock Performance
CRVL stock opened at $242.51 on Friday. CorVel has a one year low of $187.92 and a one year high of $265.14. The firm has a market cap of $4.15 billion, a price-to-earnings ratio of 56.14 and a beta of 1.08. The firm has a 50-day simple moving average of $243.19 and a two-hundred day simple moving average of $231.83.
Insider Activity at CorVel
In other news, Director Jean Macino sold 3,130 shares of the firm’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $253.42, for a total value of $793,204.60. Following the completion of the sale, the director now owns 14,160 shares of the company’s stock, valued at approximately $3,588,427.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Jean Macino sold 3,130 shares of the company’s stock in a transaction dated Thursday, February 22nd. The shares were sold at an average price of $253.42, for a total transaction of $793,204.60. Following the transaction, the director now owns 14,160 shares in the company, valued at $3,588,427.20. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Chairman V Gordon Clemons sold 1,000 shares of the stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $264.00, for a total transaction of $264,000.00. Following the completion of the transaction, the chairman now directly owns 310,534 shares of the company’s stock, valued at $81,980,976. The disclosure for this sale can be found here. Insiders sold 11,543 shares of company stock valued at $2,881,792 over the last 90 days. Insiders own 48.71% of the company’s stock.
Institutional Investors Weigh In On CorVel
About CorVel
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
See Also
- Five stocks we like better than CorVel
- What Are Dividend Achievers? An Introduction
- MarketBeat Week in Review – 4/29 – 5/3
- What is the S&P/TSX Index?
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- How to Calculate Return on Investment (ROI)
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.